Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study - MD Linx
Submitted by Anonymous (not verified) on Wed, 06/03/2020 - 21:47
